Dashboard
Manage Tickers

NLSP NLS Pharmaceutics Ltd.

Nasdaq nlspharma.com


$ 3.87 $ -0.12 (-2.99 %)    

Monday, 10-Nov-2025 17:22:38 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 623.82 $ 4.38 (0.71 %)
DIA $ 473.95 $ 1.94 (0.41 %)
SPY $ 681.69 $ 4.15 (0.61 %)
TLT $ 89.46 $ 0.06 (0.07 %)
GLD $ 380.15 $ 2.40 (0.64 %)
$ 3.89
$ 4.05
$ 3.83 x 100
$ 4.02 x 100
$ 3.80 - $ 4.21
$ 0.74 - $ 41.50
58,334
na
346,908
nm
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
10/30/2025 23:50:05

Core News & Articles
NLS Pharma And Aexon Labs Expand DOXA Plat...
10/30/2025 11:15:50

DOXA Platform Expansion Strengthens Cognitive, Arousal, and Neuroprotective ProgramsSupported by Solid Cash Position and Strate...

nls-pharmaceutics-plans-to-effect-a-reverse-share-split-at-1-for-10-effective-october-31-under-the-new-trading-symbol-ncel-and-new-name-newcelx-following-the-anticipated-closing-of-the-merger-with-kadimastem
NLS Pharmaceutics Plans To Effect A Revers...
10/29/2025 10:11:18

nls-pharmaceutics-and-kadimastem-sign--mou-to-jointly-develop-gene-edited-cell-therapy-products
NLS Pharmaceutics And Kadimastem Sign MOU...
10/27/2025 11:04:30

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/23/2025 12:07:49

Core News & Articles
NLS Pharmaceutics, Kadimastem Receive Appr...
10/23/2025 10:04:15

NLS Pharmaceutics Ltd. (NASDAQ:NLSP) (NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmac...

nls-pharmaceutics-h1-eps-105-up-from-194-yoy
NLS Pharmaceutics H1 EPS $(1.05) Up From $...
10/06/2025 10:49:58

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/30/2025 12:09:34

nls-pharmaceutics-shareholders-approve-merger-with-kadimastem
NLS Pharmaceutics Shareholders Approve Mer...
09/30/2025 11:06:20

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
09/26/2025 12:10:27

Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The ...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/18/2025 12:09:24

nls-pharmaceutics-and-kadimastem-announce-sec-effectiveness-of-registration-statement-on-form-f-4-for-planned-merger-into-newcelx-ltd
NLS Pharmaceutics And Kadimastem Announce ...
09/10/2025 10:12:34

nls-pharmaceutics-and-merger-partner-kadimastem-announce-a-hong-kong-patent-covering-kadimastems--cell-selection-and-enrichment-technology-for-isletrx
NLS Pharmaceutics And Merger Partner Kadim...
09/04/2025 11:43:22

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/26/2025 17:06:55

reported-monday-august-25-2025-nls-pharmaceutics-postpones-shareholders-meeting-on-kadimastem-merger-to-september-16-to-address-sec-feedback-and-provide-updated-information
Reported Monday August 25, 2025: NLS Pharm...
08/26/2025 16:52:47

On August 21, 2025, the board of directors of NLS Pharmaceutics Ltd. (the "Company") rescheduled the meeting date of th...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
08/25/2025 21:07:30

nls-pharmas-diabetes-treatment-project-gets-fresh-funding-boost-from-us-israel-foundation
NLS Pharma's Diabetes Treatment Project Ge...
07/17/2025 11:02:41

NLS Pharmaceutics Ltd. (NASDAQ:NLSP) ("NLS"), a Swiss clinical-stage biopharmaceutical company focused on central nervo...

why-greenbrier-shares-are-trading-higher-by-over-13-here-are-20-stocks-moving-premarket
Why Greenbrier Shares Are Trading Higher B...
07/02/2025 09:55:00

Shares of The Greenbrier Companies, Inc. (NYSE: GBX) rose sharply in today's pre-market trading after the company posted st...

nls-pharma-completes-second-and-final-1m-closing-of-3m-equity-financing-of-preferred-shares-and-warrants-from-march-2025
NLS Pharma Completes Second And Final $1M ...
06/30/2025 11:08:15

nls-pharmaceutics-announces-that-it-will-present-new-preclinical-data-on-mazindol-er-at-the-2025-annual-meeting-of-the-american-society-of-clinical-psychopharmacology
NLS Pharmaceutics Announces That It Will P...
05/21/2025 11:32:16

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION